Medicare Enrolled

Dr. Waleed El-Feky, M.D.

Neurology · Dallas, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
6080 N CENTRAL EXPY STE 100, Dallas, TX 75206
2148273610
In practice since 2006 (20 years)
NPI: 1528033362 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. El-Feky from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. El-Feky? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. El-Feky

Dr. Waleed El-Feky is a neurology in Dallas, TX, with 20 years in practice. Based on federal Medicare data, Dr. El-Feky performed 47,193 Medicare services across 1,594 unique beneficiaries.

Between the years covered by Open Payments, Dr. El-Feky received a total of $434,677 from 73 pharmaceutical and/or device companies across 1272 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. El-Feky is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 2% volume in TX$ $434,677 industry payments

Medicare Practice Summary

Medicare Utilization ↗
47,193
Medicare services
Top 2% in TX for neurology
1,594
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,360 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
MRI contrast dye injection (gadoterate)20,980$0$1
Capsaicin pain patch (Qutenza)19,600$3$10
Botox injection, per unit4,745$5$20
Office visit, established patient (30-39 min)644$88$330
Office visit, established patient (20-29 min)285$63$225
Needle measurement of electrical activity in arm or leg muscles, complete study159$77$102
New patient office visit (45-59 min)157$120$500
Mri scan of brain before and after contrast110$168$1,530
Office visit, established patient, complex (40-54 min)72$125$440
Sleep study including heart rate, breathing, airflow, and effort62$70$520
Nerve conduction, 9-10 studies50$163$715
New patient office visit (30-44 min)40$75$330
New patient office visit, complex (60-74 min)36$174$630
Punch biopsy, each additional skin growth35$46$198
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle34$61$165
Mri scan of lower spinal canal without contrast25$97$990
Mri scan of blood vessels of head without contrast23$91$1,225
Nerve conduction, 11-12 studies22$191$800
Destruction of peripheral nerve or branch21$287$800
Mri scan of upper spinal canal without contrast20$97$975
Punch biopsy, first skin growth18$94$402
Mri scan of brain without contrast17$102$1,115
Mri scan of blood vessels of neck before and after contrast16$211$1,856
Nerve conduction, 5-6 studies11$107$445
Office visit, established patient (10-19 min)11$39$135
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$434,677
Total received (2018-2024)
Avg $62,097/year across 7 years
Top 2% in TX for neurology
73
Companies
1,272
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$393,232 (90.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$27,697 (6.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,748 (3.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$201,246
2023
$93,556
2022
$89,819
2021
$17,550
2020
$9,184
2019
$11,140
2018
$12,182

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Averitas Pharma Inc.
$110,448
Biogen, Inc.
$53,976
GRT US Holding, Inc.
$53,271
Ipsen Biopharmaceuticals, Inc
$51,528
Amgen Inc.
$28,052
Lilly USA, LLC
$21,187
Allergan, Inc.
$20,701
Allergan Inc.
$19,024
Axsome Therapeutics, Inc.
$17,156
E.R. Squibb & Sons, L.L.C.
$16,682
Horizon Therapeutics plc
$10,551
ABBVIE INC.
$9,115
JAZZ PHARMACEUTICALS INC.
$4,065
UCB, Inc.
$3,942
Acorda Therapeutics, Inc
$2,931
Eli Lilly and Company
$1,400
Sunovion Pharmaceuticals Inc.
$1,111
Celgene Corporation
$1,078
Novartis Pharmaceuticals Corporation
$978
Genentech USA, Inc.
$887
ACADIA Pharmaceuticals Inc
$703
Teva Pharmaceuticals USA, Inc.
$494
Eisai Inc.
$488
GENZYME CORPORATION
$430
TG Therapeutics, Inc.
$385
EMD Serono, Inc.
$378
PFIZER INC.
$362
Merz Pharmaceuticals, LLC
$350
AbbVie Inc.
$327
Alexion Pharmaceuticals, Inc.
$284
Amneal Pharmaceuticals LLC
$154
SK Life Science, Inc.
$138
Biohaven Pharmaceuticals, Inc.
$123
Grifols USA, LLC
$118
ARGENX US, INC.
$108
Kyowa Kirin, Inc.
$104
Lundbeck LLC
$98
CSL Behring
$91
Avanir Pharmaceuticals, Inc.
$86
Avion Pharmaceuticals
$85
Janssen Pharmaceuticals, Inc
$84
Neurocrine Biosciences, Inc.
$82
Sumitomo Pharma America, Inc.
$81
Abbott Laboratories
$76
MERZ NORTH AMERICA, INC.
$67
Siemens Medical Solutions USA, Inc.
$64
Adamas Pharmaceuticals, Inc.
$62
Inspire Medical Systems, Inc.
$60
AbbVie, Inc.
$50
Corium, LLC
$49
TG THERAPEUTICS, INC.
$48
Takeda Pharmaceuticals U.S.A., Inc.
$46
CATALYST PHARMACEUTICALS, INC.
$45
Harmony Biosciences LLC
$45
Biohaven Pharmaceutical Holding Company Ltd.
$45
ARBOR PHARMACEUTICALS, INC.
$37
Mitsubishi Tanabe Pharma America, Inc.
$35
Arbor Pharmaceuticals, Inc.
$35
HARMONY BIOSCIENCES LLC
$32
Merz North America, Inc.
$29
HOSPIRA, INC.
$26
Harmony Biosciences Llc
$24
Alnylam Pharmaceuticals Inc.
$18
Avid Radiopharmaceuticals, Inc.
$17
Medtronic USA, Inc.
$17
Assertio Therapeutics, Inc.
$17
Promius Pharma LLC
$16
GE HEALTHCARE
$15
Greenwich Biosciences, Inc.
$15
IDORSIA PHARMACEUTICALS US INC
$14
Upsher-Smith Laboratories LLC
$13
Supernus Pharmaceuticals, Inc.
$13
Bayer HealthCare Pharmaceuticals Inc.
$11
Top 3 companies account for 50.1% of total payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Austedo XR · BOTOX · BRIUMVI · Betaseron · Briviact · CAMBIA · COPAXONE · Confirm Rx · DAYBUE · DUOPA · DYSPORT · Dhivy · Duopa · Dysport · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · FIRDAPSE · Fintepla · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · INSPIRE · KESIMPTA · KISUNLA · KYNMOBI · LEADPOINT · LEMTRADA · LUMIZYME · LYRICA · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OXTELLAR XR · Ongentys · PANZYGA · POMPE - DISEASE · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · QUVIVIQ · Qutenza · RYTARY · Radicava · Rebif · SOLIRIS · SUNOSI · Skyclarys · Sunosi · TECFIDERA · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VERSANT kPCR Molecular System SP · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · WAKIX · Wakix · XEOMIN · XYWAV · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · Zinbryta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for neurology in TX.

Equivalent to $921 per 100 Medicare services performed
Looking for a neurology in Dallas?
Compare neurologys in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
241
Per 100K population
9.3
County median income
$74,149
Nearest hospital
BAYLOR SCOTT AND WHITE MEDICAL CENTER UPTOWN
2.3 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. El-Feky is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (speaking/promotional, top 2%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. El-Feky experienced with mri contrast dye injection (gadoterate)?
Based on Medicare claims data, Dr. El-Feky performed 20,980 mri contrast dye injection (gadoterate) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. El-Feky receive payments from pharmaceutical companies?
Yes. Dr. El-Feky received a total of $434,677 from 73 companies across 1,272 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. El-Feky's costs compare to other neurologys in Dallas?
Dr. El-Feky's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. El-Feky) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →